Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (3296)	4/2/2001 12:40:52 PM
From: nigel bates	Read Replies (1) \| Respond to of 52153

Peter, you are an unbelievable cynic. You missed out the <g>. There was an interesting article in the weekend press (IOS, I think) on impending corporate tax changes in Germany. The gist was that it will soon become far more attractive for German companies to make acquisitions, especially where acquired R&D is concerned. Biotech was mentioned as the sector where the effects would be felt first. Hope to see some activity in Europe over the next 12 months. nig (edit) time to make dinner...